Seners Pierre, Hurford Robert, Tisserand Marie, Turc Guillaume, Legrand Laurence, Naggara Olivier, Mas Jean-Louis, Oppenheim Catherine, Baron Jean-Claude
From the Departments of Neurology (P.S., G.T., J.-L.M., J.-C.B.) and Radiology (L.L., O.N., C.O.), Hôpital Sainte-Anne, Paris, France; Université Paris Descartes, Sorbonne Paris Citeé, INSERM UMR S894, DHU Neurovasc, France (P.S., G.T., L.L., O.N., J.-L.M., C.O., J.-C.B.); Department of Clinical Neurosciences, University of Cambridge, United Kingdom (R.H.); and Service de Radiologie, Hoôpital Foch, Suresnes, France (M.T.).
Stroke. 2017 Feb;48(2):348-352. doi: 10.1161/STROKEAHA.116.015414. Epub 2016 Dec 29.
Early neurological deterioration (END) after anterior circulation stroke is strongly associated with poor outcome. Apart from straightforward causes, such as intracerebral hemorrhage and malignant edema, the mechanism of END occurring after intravenous thrombolysis remains unclear in most instances. We tested the hypothesis that unexplained END is associated with thrombus extension.
From our database of consecutively thrombolysed patients, we identified anterior circulation stroke patients who had both admission and 24-hour T2* magnetic resonance imaging, visible occlusion on admission magnetic resonance angiography and no recanalization on 24-hour magnetic resonance angiography. END was defined as ≥4 National Institutes of Health Stroke Scale-point deterioration on 24-hour clinical assessment and unexplained END as END without clear cause. The incidence of susceptibility vessel sign extension on T2* imaging, defined as any new occurrence or extension of susceptibility vessel sign from admission to 24-hour follow-up magnetic resonance, was compared between patients with unexplained END and those without END.
Of 120 eligible patients for the present study, 22 experienced unexplained END. Susceptibility vessel sign extension was present in 41 (34%) patients and was significantly more frequent in the unexplained END than in the no-END group (59% versus 29%, respectively; adjusted odds ratio=3.96; 95% confidence interval, 1.25-12.53; P=0.02).
In this study, unexplained END occurring after thrombolysis was independently associated with susceptibility vessel sign extension, suggesting in situ thrombus extension or re-embolization. These findings strengthen the need to further investigate early post-thrombolysis administration of antithrombotics to reduce the risk of this ominous clinical event.
前循环卒中后的早期神经功能恶化(END)与不良预后密切相关。除了脑出血和恶性水肿等直接原因外,大多数情况下静脉溶栓后发生END的机制仍不清楚。我们检验了一个假设,即不明原因的END与血栓扩展有关。
从我们连续接受溶栓治疗的患者数据库中,我们确定了那些既进行了入院时和24小时的T2磁共振成像、入院磁共振血管造影可见闭塞且24小时磁共振血管造影未再通的前循环卒中患者。END定义为24小时临床评估时美国国立卫生研究院卒中量表评分恶化≥4分,不明原因的END定义为无明确原因的END。比较不明原因的END患者和无END患者在T2成像上易损血管征扩展的发生率,易损血管征扩展定义为从入院到24小时随访磁共振成像上新出现或扩展的易损血管征。
在本研究的120例符合条件的患者中,22例经历了不明原因的END。41例(34%)患者出现易损血管征扩展,不明原因的END组比无END组更频繁(分别为59%和29%;调整后的优势比=3.96;95%置信区间,1.25 - 12.53;P = 0.02)。
在本研究中,溶栓后发生的不明原因的END与易损血管征扩展独立相关,提示原位血栓扩展或再栓塞。这些发现强化了进一步研究溶栓后早期给予抗栓药物以降低这一不良临床事件风险的必要性。